false 0001090872 0001090872 2022-03-16 2022-03-16

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 16, 2022

 

AGILENT TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-15405

 

77-0518772

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

 

 

5301 Stevens Creek Boulevard, Santa Clara, CA

 

95051

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code (800) 227-9770

  

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

          Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.01 Par Value

 

A

 

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 


 


 

 

Item 5.07Submission of Matters to a Vote of Security Holders

 

The Annual Meeting of Stockholders of the Company was held on March 16, 2022 (the “Annual Meeting”). A total of 266,837,916 shares of Common Stock, representing approximately 88.84% of the shares outstanding, were represented at the Annual Meeting. The voting results for each item of business presented at the Annual Meeting, as certified by the Company’s independent inspector of elections, are set forth below:  

 

Proposal No. 1

The election of three (3) directors for a term of three years. The individuals listed below received the affirmative vote of a majority of the votes cast by the shares present in person or represented by proxy and entitled to vote at the Annual Meeting and were each elected to serve a three-year term.

 

Name

For

Against

Abstain

Broker Non-Vote

Hans E. Bishop

219,566,395

26,056,611

444,401

20,770,508

Otis W. Brawley, M.D.

241,120,057

4,497,367

449,983

20,770,508

Mikael Dolsten, M.D., Ph.D.

234,934,495

10,673,089

459,823

20,770,508

 

Directors Mala Anand, Koh Boon Hwee, Heidi Kunz, Michael R. McMullen, Daniel K. Podolsky, M.D., Sue H. Rataj, George A. Scangos, Ph.D. and Dow R. Wilson continued in office following the Annual Meeting.

 

Proposal No. 2

The non-binding advisory vote to approve the compensation of the Company’s named executive officers was approved as set forth below.

 

For

Against

Abstain

Broker Non-Vote

216,898,569

28,651,613

517,124

20,770,508

 

Proposal No. 3

The proposal to ratify the Audit and Finance Committee’s appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2022 fiscal year was approved as set forth below.

 

For

Against

Abstain

Broker Non-Vote(1)

248,388,336

17,949,546

500,033

-0-

 

Proposal No. 4

The stockholder proposal regarding the right to call a special meeting was approved as set forth below.

 

For

Against

Abstain

Broker Non-Vote(1)

200,652,664

44,840,290

574,270

20,770,508

 

 

(1)

Pursuant to the rules of the New York Stock Exchange, this proposal constituted a routine matter. Therefore, brokers were permitted to vote without receipt of instructions from beneficial owners.

 


 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

AGILENT TECHNOLOGIES, INC.

 

 

 

 

 

By:

/s/P. Diana Chiu

 

Name:

P. Diana Chiu

 

Title:

Vice President, Assistant General Counsel

& Assistant Secretary

 

 

 

 

 

 

 

Date: March 17, 2022